Detalhe da pesquisa
1.
[Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma].
Zhonghua Yu Fang Yi Xue Za Zhi
; 46(6): 527-32, 2012 Jun.
Artigo
em Chinês
| MEDLINE | ID: mdl-22943900
2.
RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
Sci Rep
; 10(1): 14538, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883983
3.
Expression of CIITA-related MHCII molecules in tumors linked to prognosis in hepatocellular carcinoma.
Int J Oncol
; 34(3): 681-8, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19212673
4.
[Specific suppression in regulatory T cells by Foxp3 siRNA contributes to enhance the in vitro anti-tumor immune response in hepatocellular carcinoma patients].
Beijing Da Xue Xue Bao Yi Xue Ban
; 41(3): 313-8, 2009 Jun 18.
Artigo
em Chinês
| MEDLINE | ID: mdl-19727215
5.
Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.
Am J Cancer Res
; 9(6): 1183-1200, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285951
6.
Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chin Med J (Engl)
; 132(13): 1572-1581, 2019 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31188160
7.
Effect of Upregulated DNA Replication and Sister Chromatid Cohesion 1 Expression on Proliferation and Prognosis in Hepatocellular Carcinoma.
Chin Med J (Engl)
; 131(23): 2827-2835, 2018 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511685
8.
Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus.
Chin Med J (Engl)
; 128(19): 2625-31, 2015 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26415801
9.
2',3'-cyclic nucleotide 3'-phosphodiesterases inhibit hepatitis B virus replication.
PLoS One
; 8(11): e80769, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24260477
10.
Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis.
Chin Med J (Engl)
; 125(2): 306-11, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22340564
11.
In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.
Antivir Ther
; 17(5): 793-803, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22668794